This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Hatoum HT, Lin S-J, Kolsun K, Onel E.Cost-utility analysis of a rheumatologist's treatment of osteoarthritis of the knee supports the usage of hyaluronic acid (Euflexxa TM). Arthritis and Rheumatism 56 (Suppl.): 44, Sep 2007
Yousuf S, Frick KD, Hochberg M, Lao L, Berman B, Spencer C, Steinwachs D.Cost effectiveness of traditional Chinese acupuncture as adjunctive therapy in osteoarthritis of the knee. Arthritis and Rheumatism 56 (Suppl.): 83-84, Sep 2007
Vonkeman HE, Braakman-Jansen AMA, Klok RM, Postma MJ, Brouwers JRBJ, van der Laar MAFJ.Incremental cost-effectiveness of proton pump inhibitors for the prevention of NSAID ulcers: a pharmacoeconomic analysis linked to a case-control study. Arthritis and Rheumatism 56 (Suppl.): 78-79, Sep 2007
Finckh A, Bansback N, Marra C, Anis AH, Michaud K, Lubin S, White M, Gall V, Liang MH.Costs and benefits of strategies for treating new onset rheumatoid arthritis within 12 weeks. Arthritis and Rheumatism 56 (Suppl.): 81-82, Sep 2007
Losina E, Kessler CL, Walensky RP, Emrani PS, Reichmann WM, Wright EA, Solomon DH, Paltiel AD, Yelin E, Katz JN.Cost-effectiveness of total knee replacement in the US: impact of patient risk and hospital volume. Arthritis and Rheumatism 56 (Suppl.): 83, Sep 2007
Rights and permissions
About this article
Cite this article
News from ACR/AHRP. Pharmacoecon. Outcomes News 542, 5–6 (2007). https://doi.org/10.2165/00151234-200705420-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705420-00008